Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $1.56 Million - $1.74 Million
-7,474 Reduced 18.48%
32,977 $7.2 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $67,807 - $77,960
-343 Reduced 0.84%
40,451 $9.19 Million
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $211,504 - $233,228
-1,052 Reduced 2.51%
40,794 $8.2 Million
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $394,613 - $449,356
1,862 Added 4.66%
41,846 $10.1 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $119,672 - $144,642
561 Added 1.42%
39,984 $9.17 Million
Q4 2022

Feb 15, 2023

SELL
$203.72 - $248.97 $37,280 - $45,561
-183 Reduced 0.46%
39,423 $9.28 Million
Q3 2022

Nov 16, 2022

SELL
$204.81 - $262.19 $468,605 - $599,890
-2,288 Reduced 5.46%
39,606 $8.11 Million
Q2 2022

Aug 23, 2022

SELL
$213.86 - $277.87 $275,665 - $358,174
-1,289 Reduced 2.98%
41,894 $9.82 Million
Q2 2022

Aug 16, 2022

BUY
$213.86 - $277.87 $1.29 Million - $1.67 Million
6,015 Added 16.18%
43,183 $10.1 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $1.09 Million - $1.25 Million
4,205 Added 12.76%
37,168 $9.8 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $58,122 - $67,240
-214 Reduced 0.65%
32,963 $10.4 Million
Q3 2021

Nov 16, 2021

BUY
$274.82 - $308.34 $118,997 - $133,511
433 Added 1.32%
33,177 $9.34 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $199,984 - $220,843
-794 Reduced 2.37%
32,744 $9.03 Million
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $210,821 - $262,425
1,029 Added 3.17%
33,538 $8.55 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $217,002 - $248,941
1,161 Added 3.7%
32,509 $6.62 Million
Q3 2020

Nov 17, 2020

SELL
$167.03 - $201.3 $270,421 - $325,904
-1,619 Reduced 4.91%
31,348 $5.86 Million
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $14,843 - $23,899
131 Added 0.4%
32,967 $5.51 Million
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $235,554 - $440,942
2,258 Added 7.38%
32,836 $3.82 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $2.69 Million - $2.85 Million
16,438 Added 116.25%
30,578 $5.12 Million
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $36,906 - $41,141
-231 Reduced 1.61%
14,140 $2.38 Million
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $864 - $1,037
-6 Reduced 0.04%
14,371 $2.49 Million
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $80,281 - $101,438
649 Added 4.73%
14,377 $2.2 Million
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $17,398 - $25,068
-144 Reduced 1.04%
13,728 $1.74 Million
Q3 2018

Nov 15, 2018

BUY
$167.67 - $188.27 $2.03 Million - $2.28 Million
12,087 Added 677.14%
13,872 $2.41 Million
Q2 2018

Aug 13, 2018

BUY
$160.33 - $189.41 $47,618 - $56,254
297 Added 19.96%
1,785 $320,000
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $9,530 - $10,508
59 Added 4.13%
1,488 $239,000
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $211,477 - $234,284
1,429
1,429 $228,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.